Literature DB >> 15036231

Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance.

Ciriaco A Piccirillo1, Ethan M Shevach.   

Abstract

Self/non-self discrimination is a complex process that involves maintaining tolerance to autoantigens while preserving the potential to generate an effective humoral and cellular immune responses against invading pathogens. In the last decade, there has been a remarkable resurgence in research on suppressor or regulatory T cells. Few areas have captivated the attention of immunologists so vividly and entertained so many passionate debates. Indeed, CD4(+)CD25(+) Treg, which are at the very center of this fascination, have emerged as a dominant T cell population capable of mediating peripheral tolerance to autoantigens, but whose functions have now been extended to regulation of T cell responses directed to foreign antigens. However, a number of fundamental questions concerning the origin, phenotypic nature and mechanism of action of CD4(+)CD25(+) Treg cells remain elusive and misunderstood. We propose the existence of two general subsets of CD4(+)CD25(+) Treg cells, naturally-occurring and induced, that differ in their origin, developmental and activation requirements, and mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036231     DOI: 10.1016/j.smim.2003.12.003

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  115 in total

Review 1.  Genetic control of the inflammatory T-cell response in regulatory T-cell deficient scurfy mice.

Authors:  Rahul Sharma; Shyr-Te Ju
Journal:  Clin Immunol       Date:  2010-05-08       Impact factor: 3.969

2.  Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation.

Authors:  G Aleph Prieto; Yvonne Rosenstein
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

3.  Cell-autonomous role of TGFβ and IL-2 receptors in CD4+ and CD8+ inducible regulatory T-cell generation during GVHD.

Authors:  Norifumi Sawamukai; Atsushi Satake; Amanda M Schmidt; Ian T Lamborn; Priti Ojha; Yoshiya Tanaka; Taku Kambayashi
Journal:  Blood       Date:  2012-04-10       Impact factor: 22.113

4.  Absence of CD4 T-cell help provides a robust CD8 T-cell response while inducing effective memory in a preclinical model of melanoma.

Authors:  Maria Muccioli; Caitlin Longstaff; Fabian Benencia
Journal:  Immunotherapy       Date:  2012-05       Impact factor: 4.196

Review 5.  New and emerging therapies for acute and chronic graft versus host disease.

Authors:  LaQuisa Hill; Amin Alousi; Partow Kebriaei; Rohtesh Mehta; Katayoun Rezvani; Elizabeth Shpall
Journal:  Ther Adv Hematol       Date:  2017-11-28

6.  An MHC-linked locus modulates thymic differentiation of CD4+CD25+Foxp3+ regulatory T lymphocytes.

Authors:  Julie Tellier; Joost P M van Meerwijk; Paola Romagnoli
Journal:  Int Immunol       Date:  2006-08-30       Impact factor: 4.823

7.  Systemic dendritic cell mobilization associated with administration of FLT3 ligand to SIV- and SHIV-infected macaques.

Authors:  R Keith Reeves; Qing Wei; Jackie Stallworth; Patricia N Fultz
Journal:  AIDS Res Hum Retroviruses       Date:  2009-12       Impact factor: 2.205

Review 8.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

9.  Myeloid-derived suppressor cells in murine retrovirus-induced AIDS inhibit T- and B-cell responses in vitro that are used to define the immunodeficiency.

Authors:  Kathy A Green; W James Cook; William R Green
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

10.  Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma.

Authors:  Elisabetta Capriotti; Eric C Vonderheid; Christopher J Thoburn; Mariusz A Wasik; David W Bahler; Allan D Hess
Journal:  Leuk Lymphoma       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.